| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |